Navigation Links
MRI-guided Breast Biopsy Pronounced a Success

An MRI-guided breast biopsy successfully removed the breast lesion by taking x-ray of the lesion as well as slices of the lesion, according to radiologists. "Contrast-enhanced// MRI of the breast is becoming increasingly useful in patients with lesions that cannot be detected with other techniques," said Basak Erguvan-Dogan, MD, radiologist in Breast Imaging at the University of Texas M.D. Anderson Cancer Center in Houston. "However, it is hard to confirm removal of the targeted lesion because the abnormality does not enhance after being removed from the breast."

Currently, patients who have MRI-guided needle localization and excision of abnormalities may be asked to have follow-up breast MRI; if the lesion has not been successfully removed, another biopsy procedure will need to be done. "By taking x-rays of the lesion specimen, then slicing it up and taking additional x-rays, we can determine if the lesion has been removed or if additional tissue needs to be excised while the patient is still in the operating room," Dr. Erguvan-Dogan said.

Whole specimen and sliced specimen radiography was performed in 10 patients, and X-raying the lesion as a whole and in slices proved to be valuable, said Dr. Erguvan-Dogan. "In all five malignant cases, sliced specimen radiographs showed the lesion in question, helped the pathologist correctly identify the lesion while the patient was still in the operating room and helped the surgeon obtain negative surgical margins," said Dr. Erguvan-Dogan. In addition, "whole specimen radiography is able to correctly locate fractured biopsy needle localization wires, which may be removed before the patient left the operating room," she said.

Specimen radiography is routinely used in some centers after mammographically and sonographically guided needle localization and excision; however, specimen radiography following MRI-guided needle localization has not been previously reported on, Dr. Erguvan-Dogan said.

Source: Eurekalert
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held last ... Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred ... Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served APDA ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Stuart ... tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. ... with unmatched results. , Developed by Cynosure, the PicoSure has been approved by the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... On June 9-10, Las Vegas will host ... (CME) event presented by the Association for Comprehensive Care in Rare Diseases (ACCORD). ... mission is to provide education, tools, and resources to primary care clinicians that ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... , Feb. 4, 2016 Global Immunology ... market to drive long-term market growth Summary ... set of chronic disorders that affect 5–7% of ... terms of their symptoms and key patient demographics, ... of immune pathways and an inappropriate immune response. ...
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
Breaking Medicine Technology: